Energy Specific Far Infrared Radiation Treatment for AIDS

NCT00574522 · Status: UNKNOWN · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 3

Last updated 2009-08-17

No results posted yet for this study

Summary

The investigators are proposing that energy specific electromagnetic radiation of the central nervous system, the viscera and the endocrine system has the potential to enhance the immune system; thereby enhancing the production of killer cells to fight and destroy the human immunodeficiency virus.

Conditions

  • HIV Infections

Interventions

RADIATION

Far infrared

Far infrared radiation with the wavelength between 5μm and 20μm for 30 to 40 minutes per session.

Sponsors & Collaborators

  • GAAD Medical Research Institute Inc.

    lead OTHER

Principal Investigators

  • Ken Nedd, M.D. · GAAD Medical Research Institute Inc.

  • Kwasi Donyina, Ph.D. · GAAD Medical Research Institute Inc.

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-02-29
Primary Completion
2009-08-31
Completion
2009-11-30

Countries

  • Canada

Study Locations

Related Clinical Trials

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00574522 on ClinicalTrials.gov